STAT3 and polycystic ovary syndrome: As shown in Figure 4, there was no significant difference in the expression of JAK2 and STAT3 among all the groups, but the phosphorylation of JAK2 and STAT3 were significantly increased in the IL-6 treated PCOS rats when compared with the PCOS rats (Figure 4E).